Time to ban direct-to-consumer prescription drug marketing

Annals of Family Medicine

Volumn 5, Issue 2, 2007, Pages 101-104

  Stange, Kurt C ^a  

^a NONE

Author keywords

Advertising direct to consumer; Doctor patient relationship; Drug industry; Public health

Indexed keywords

DECISION MAKING; DOCTOR PATIENT RELATION; DRUG CONTROL; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG USE; EDITORIAL; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; MEDICAL INFORMATION; PHARMACY; PRESCRIPTION;

ADVERTISING; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEW ZEALAND; PHYSICIAN-PATIENT RELATIONS; PUBLIC HEALTH; UNITED STATES;

EID: 34047112781     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.693     Document Type: Editorial

References (35)

1. Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK. Creating demand for prescription drugs: a content analysis of television direct-to-consumer- advertising. Ann Fam Med. 2007;5(1):6-13.
2. Stange KC. On TRACK: Intended and unintended consequences of direct-to-consumer drug marketing. Ann Fam Med. 2007;5(2):175-179.
3. Kessler DA, Levy DA. Direct-to-consumer advertising: is it too late to manage the risks? Ann Fam Med. 2007;5(1):4-5.
4. Glinert LH. TV commercials for prescription drugs: a discourse analytic perspective. Res Social Adm Pharm. 2005;1(2):158-184.
5. Sumpradit N, Ascione FJ, Bagozzi RP. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising. Clin Ther. 2004;26(1):135-154.
6. Kaphingst KA, DeJong W, Rudd RE, Daltroy LH. A content analysis of direct-to-consumer television prescription drug advertisements. J Health Commun. 2004;9(6):515-528.
7. Almasi EA, Stafford RS, Kravitz RL, Mansfield PR What are the public health effects of direct-to-consumer drug advertising? PLoS Med. 2006;3(3):e145. Epub 2006 Mar 28.
8. Klausner JD, Kim A, Kent C. Are HIV drug advertisements contributing to increases in risk behavior among men in San Francisco, 2001? AIDS. 2002;16(17):2349-2350.
9. Hansen RA, Shaheen NJ, Schommer JC. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clin Ther. 2005;27(9):1478-1487.
10. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14(4):246-250.
11. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002.
12. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42(12):1176-1185.
13. Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract. 2004;17(1):6-18.
14. Morgan S, Mintzes, B, Barer M. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? J Health Serv Res Policy. 2003;8:237-244.
15. Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood). 2006;25(5):1371-1377.
16. Kravitz RL. Towards a framework for improving DTCA [eletter]. http://www.annfammed.org/cgi/eletters/5/1/6#5211, 4 February 2007.
17. Mintzes B, Barer ML, Kravitz RL, et al. How does direct-toconsumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169(5):405-412.
18. Robinson AR, Hohmann KB, Rifkin JI, et al. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med. 2004;164(4):427-432.
19. Lacasse JR, Leo J. Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Med. 2005;2:e392 DOI: 10.1371/journal.pmed.0020392.
20. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358(9288)1141-1146.
21. Deyo RA, Patrick DL. Hope or Hype: The Obsession With Medical Advances and the High Cost of False Promises. New York, NY: New York American Management Association; 2005.
22. Rubin R. Analysis: Prescription drug ads leave out risks, alternatives. USA Today. Available at: http://www.usatoday.com/news/health/2007-01-29- prescription-drug-ad_x.htm. Accessed: 2 March 2007.
23. PhRMA. Guiding Principles: Direct-to-Consumer Advertisements About Prescription Medicines. Available at: http://www.phrma.org/files/ DTCGuidingprinciples.pdf. Accessed 2 March 2007.
24. Novartis Pharmaceuticals Corporation. Your search for relief may be over [advertisement]. Available at: http://www.zelnorm.com/index.jsp?source= 01030&campaign=ZEL-9648&site=100005&placement=100196&creative= 100002. Accessed: 3 March 2007.
25. Kaphingst KA, Rudd RE, DeJong W, Daltroy LH. Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy. J Health Commun. 2005;10(7):609-619.
26. Hoek J, Maubach N. Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines. N Z Med J. 2007;120(1249):U2425.
27. Welch Cline RJ, Young HN. Marketing drugs, marketing health care relationships: a content analysis of visual cues in direct-to-consumer prescription drug advertising. Health Commun. 2004;16(2):131-157.
28. Mintzes B. Television advertisements for medicines and the myth of the magic pill [eletter]. http://www.annfammed.org/cgi/eletters/5/1/6#5135, 30 January 2007.
29. Scott JG. Selling soap [eletter]. http://www.annfammed.org/cgi/eletters/ 5/1/6#5176, 1 February 2007.
30. Brody H. Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry. Lanham, MD: Rowman and Littlefield; 2007.
31. Abramson J. Overdosed America: The Broken Promise of American Medicine. New York, NY: HarperCollins; 2004:156-157.
32. Allen RE. End direct-to-DOCTOR advertising, not DTCA [eletter]. http://www.annfammed.org/cgi/eletters/5/1/6#5239 8 February 2007.
33. Brody H. What part of "selling" don't you understand [eletter]? http://www.annfammed.org/cgi/eletters/5/1/6#5158, 1 February 2007.
34. Brody H. Reply to AE [eletter]. http://www.annfammed.org/cgi/eletters/3/ 1/82#5093, 21 January 2007.
35. Woloshin S, Schwartz LM, Welch HG. The value of benefit data in direct-to-consumer drug ads. Health Aff (Millwood). 2004;(Suppl Web Exclusives)W4-234-245.